Anagenics Ltd
ASX:AN1
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| AU |
A
|
Anagenics Ltd
ASX:AN1
|
6.9m AUD |
Loading...
|
|
| FR |
|
L'Oreal SA
PAR:OR
|
197B EUR |
Loading...
|
|
| UK |
|
Unilever PLC
LSE:ULVR
|
107.9B GBP |
Loading...
|
|
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.2T INR |
Loading...
|
|
| UK |
|
HALEON PLC
LSE:HLN
|
33.2B GBP |
Loading...
|
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
34.7B USD |
Loading...
|
|
| DE |
|
Beiersdorf AG
XETRA:BEI
|
18.3B EUR |
Loading...
|
|
| JP |
|
Kao Corp
TSE:4452
|
2.8T JPY |
Loading...
|
|
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.1T INR |
Loading...
|
|
| IN |
|
Dabur India Ltd
NSE:DABUR
|
848.1B INR |
Loading...
|
|
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD |
Loading...
|
Market Distribution
| Min | -6 907 100% |
| 30th Percentile | 21.6% |
| Median | 38.3% |
| 70th Percentile | 58.2% |
| Max | 2 095.9% |
Other Profitability Ratios
Anagenics Ltd
Glance View
Anagenics Ltd. operates as a biotechnology company, which engages in the development and marketing of therapies and diagnostic tests for inflammatory and fibrotic diseases, cancer, ischemic diseases of the heart, and hair loss. The company is headquartered in Sydney, New South Wales. The company went IPO on 2005-12-09. The principal activities of the Company include the development, distribution and sale of health, beauty and wellness products (Consumer health). The firm through its wholly owned subsidiary Advangen Pty Ltd, develops, manufactures, markets, distributes to retailers, and sells its anti-aging products globally, with its FGF5 inhibitor, hair health and hair growth products. The flagship anti-aging hair care range, marketed as evolis, Advangen Jo-Ju, and Lexilis brands are sold in Australia, Japan, and the United States of America. The Company’s subsidiary is BLC Cosmetics Pty Limited, which is the distributor of premium Australian and international beauty and wellness brands, primarily to salons and spas.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Anagenics Ltd is 47.1%, which is above its 3-year median of 44.2%.
Over the last 3 years, Anagenics Ltd’s Gross Margin has decreased from 54.7% to 47.1%. During this period, it reached a low of 38.7% on Dec 31, 2024 and a high of 54.7% on Jun 30, 2022.
